ABSTRACT -Although phospholipidosis (PLD) often affects drug development, there is no convenient in vitro or in vivo test system for PLD detection. In this study, we developed an in silico PLD prediction method based on the PLD-inducing mechanism. We focused on phospholipid (PL)-compound complex formation, which inhibits PL degradation by phospholipase. Thus, we used some molecular interactions, such as electrostatic interactions, hydrophobic interactions, and intermolecular forces, between PL and compounds as descriptors. First, we performed descriptor screening for intermolecular force and then developed a new in silico PLD prediction using descriptors related to molecular interactions. Based on the screening, we identified molecular refraction (MR) as a descriptor of intermolecular force. It is known that ClogP and most-basic pKa can be used for PLD prediction. Thereby, we developed an in silico prediction method using ClogP, most-basic pKa, and MR, which were related to hydrophobic interactions, electrostatic interactions, and intermolecular forces. In addition, a resampling method was used to determine the cut-off values for each descriptor. We obtained good results for 77 compounds as follows: sensitivity = 95.8%, specificity = 75.9%, and concordance = 88.3%. Although there is a concern regarding false-negative compounds for pKa calculations, this predictive ability will be adequate for PLD screening.
INTRODUCTION
Phospholipidosis (PLD) is a lipid storage disorder caused by the accumulation of phospholipid (PL), some drugs, or PL-drug complexes within the lysosome. Some hERG channel blockers also induce PLD (Sun et al., 2013) . Therefore some PLD assessment methods have been developed, such as in vitro screenings (Kasahara et al., 2006; Fujimura et al., 2007; Nioi et al., 2007) , toxicogenomic approaches (Sawada et al., 2005) , and some biomarkers for PLD in clinical trials (Baronas et al., 2007) . Some in silico method that can predict PLD potential would be a significant tool for planning a study package for assessing PLD. Therefore, it is hoped that useful and convenient methods to assess PLD risk or evaluate the PLD-inducing potential of therapeutics will become available.
PLD is known to be caused by cationic amphiphilic drugs (CADs) (Halliwell, 1997) . The mechanisms of the development of PLD are as follows: (1) phospholipase inhibition, (2) PL-compound complex formation, (3) PL transportation alternation, and (4) acceleration of PL biosynthesis (Anderson and Borlak, 2006) . Among these, we focused on the PL-compound complex mechanism because PL-compound complex inhibits PL degradation by phospholipase and results in accumulation of PL. The structural features of PL are cationic, anionic, hydrophobic, and amphiphilic. Therefore, PL can engage in multiple molecular interactions, leading to speculation that complex formation between PL and CADs would be induced by intermolecular interactions between these moieties.
The driving forces of the interaction are believed to be hydrophobic interactions, electrostatic interactions, and intermolecular forces (van der Waals interaction). We eliminated hydrogen bonding as a candidate factor because electrostatic interactions will take priority over hydrogen bonding due to the presence of co-existing cation and anion moieties within a PL molecule. Some in silico tools for PLD prediction have been previously reported. These tools used some physicochemical properties such as (C)logP ow (ClogP, hydrophobicity), most basic pKa (MB-pKa, cationic) or net charge (Pleoman et al., 2004; Tomizawa et al., 2006) , and the volume of distribution (Hanumegowda et al., 2010) . Some models also have been reported such as toxicophore model (Goracci et al., 2015) and Bayesian model (Pelletier et al., 2007) . In this research, we replaced these physicochemical properties as follows: ClogP is a descriptor for hydrophobic interactions, and most basic pKa and net charge are descriptors for electrostatic interactions. Therefore, we conducted two investigations in this article: (1) new descriptor screening for intermolecular forces and (2) the establishment of an in silico method for PLD prediction based on intermolecular interactions between CADs and PL.
MATERIALS AND METHODS

Total dataset
We prepared a dataset including 77 compounds, with 48 compounds having positive results and 29 compounds having negative results for in vitro studies (Amberg et al., 2011; Fischer et al., 2012; Sawada et al., 2005; Tomizawa et al., 2006) . The positive results were employed in the case of conflicting results for the same compounds in different reports. We removed some compounds with differing results between in vitro and in vivo studies. The dataset included aminoglycoside antibiotics, fluoroquinolones, macrolide antibiotics, CADs (e.g., amiodarone and chloroquine), and tetracyclines.
Calculation of physicochemical properties
Drawn chemical structures (ChemBioDraw®Ultra, Cambridge software version 12.0.2, PerkinElmer Japan, Tokyo, Japan) were used to calculate ClogP, MB-pKa, molar refraction (MR), acceptable area, molecular weight, molecular area, and rotatable bond number.
Receiver operating characteristic (ROC) analysis
ROC analysis was performed using JMP ® (version 11.0.1, SAS Institute Japan, Tokyo, Japan). We used the in vitro PLD results as the objective variables and each descriptor as an explanatory variable for nominal scale logistic regression. In brief, the predictive potential of a descriptor (explanatory variable) for the objective variable was evaluated by ROC analysis, and the obtained area under of the curve (AUC) was used as the result.
Compounds sampling from the dataset
The positive or negative compounds were sorted by name, and a random number was added for each compound. Then, the positive or negative compounds were sorted by random numbers, and 24 positive and 14 negative compounds were selected in descending order. We repeated this process 10 times and calculated the mean and standard deviation (S.D.). This process was performed using Microsoft Excel (Microsoft Inc. 14.0.60.23.1000, 32 bit).
RESULTS
Descriptor screening for intermolecular force
We assessed five physicochemical properties likely to be related to intermolecular force using ChemBioDraw ® Ultra. For the screening, we used ROC analysis to evaluate the PLD predictive ability of each physicochemical property (Table 1) . As the result, MR was an ideal descriptor for PLD prediction because it displayed the largest AUC (AUC = 0.73348, middle-high co-relationship; Vanagas, 2004) .
We identified MR as a descriptor of intermolecular force for in silico PLD prediction. Intermolecular force has a relationship with the boiling or melting point, and the boiling point is proportional to refraction (Katagiri and Uneyama, 2001) . Therefore, it appears acceptable to use MR as a descriptor for intermolecular force.
Establishment of an in silico PLD prediction method
We used ClogP as a hydrophobic interaction descriptor, MB-pKa as an electrostatic interaction descriptor, and MR as an intermolecular force descriptor to establish an in silico PLD prediction method. We previously used the Table 1 . The result of ROC analysis for descriptor screening for intermolecular force.
method to set the cut-off line in a similar manner as an in silico prediction tool for phototoxicity (Haranosono et al., 2014) , and there is knowledge of a mutagenicity prediction method using a similar algorithm (Yuta, 2010) .
In the previous report, we used one training dataset and one cross-validation dataset. However, it was noted that the cut-off line would have some dispersions during process training or depend on the validation dataset from one total dataset. Therefore, we conducted randomsampling of compounds to create one training dataset to set cut-off lines and then repeated this process 10 times to obtain the mean and S.D. of the cut-off lines (bootstrap resampling method; Efron, 1979) . This averaged cut-off line will be robust for structural variation.
We selected compounds at random and created one training dataset consisting of 24 positive and 14 negative compounds. The compounds of the training dataset were plotted for each descriptor and in vitro PLD ( Fig. 1 and Fig. 2 ). This 2D plot was used to set two cut-off lines for each descriptor (Table 2) . We set a criterion for the cut-off line to the positive and negative zones to achieve over 75% concordance. For all descriptors, there were "gray zone" which were co-existed of positive and negative compounds at similar rate. The gray zone was found between the two cut-off lines for MR or ClogP (Fig. 1 , two-sided arrows). For MB-pKa, there were two gray zones above the positive area and between the two cut-off lines (Fig. 2 , two-sided arrows). Each compound was given a "score" for each descriptor as follows: positive zone = +1, negative zone = −1, and gray zone = 0. The scores of ClogP, MR, and MBpKa were summed to combine these descriptors in this prediction method, and the summed score was defined as "total score" for each compound. The compounds with the total score +3, +2, or +1 were all positive. On the other side, the compound with the total score −3, −2, or −1 were all negative. To achieve the best concordance, we defined "the total score was 0 or above" as the positive area and "the total score was lower than zero" as the negative area. Based on this rule, we obtained "concordance = 81.6%" as the result for the training set.
In addition, we repeated this process 10 times to reduce the influence of dispersion of the training dataset (a resampling method), and obtained the mean and S.D. of the cut-off lines (Table 3 ). The total data validation was ana- 
323
In silico phospholipidosis prediction focused on phospholipid-compound interactions lyzed using this mean cut-off line, and a good result was obtained as follows: sensitivity = 95.8%, specificity = 75.9%, positive rate = 86.8%, negative rate = 91.7%, concordance = 88.3%, and adoption rate = 100% (Table 4 , Fig. 3 ). This in silico method exhibited high sensitivity and good concordance. There was one false positive at the areas of total score +1, +2, and +3; there were two false negative at the areas of total score −1, −2, and −3 (Fig. 3) .
DISCUSSION
Although reports of an in vitro validation study for PLD evaluation (Park et al., 2012) and screening studies exist (Kasahara et al., 2006; Kikkawa et al., 2005) , the prediction or screening method for PLDs remains under development. Thus, an in silico method that can predict PLD potential would be a significant tool for planning a study package for assessing PLD. In this study, we focused on the interactions between PL and compounds as the key event of phospholipase inhibition. The interactions included hydrophobic interactions, electrostatic interactions, and intermolecular forces, and we identified MR as the descriptor of intermolecular force concerning PLD development. We focused on the mechanism and key event of PLD development, and the mechanism-based descriptors achieved high concordance for chemicals rich in structural diversity. Therefore, it is indicated that investigation of descriptors related to the toxicity mechanism For example, "Negative-Gray" means the location of the cut-off line between negative zone and gray zone. is important for in silico toxicity prediction. On the other hands, some CADs are known to induce PLD in specific tissue (e.g., gentamicin-kidney; Kacew, 1985) . We consider that in vivo PLD prediction will require some pharmacokinetics parameters, such as metabolism and cell membrane permeability. In particular, safety assessments of drug metabolites are important for in vivo PLD combined with hepatotoxicity (Minagawa et al., 2012; Naito et al., 2007) .
There were nine falsely predicted compounds, including seven false positives and two false negatives. From the viewpoint of toxicity assessment, a false negative is undesirable. The false negatives were lidocaine and clociguanil. Lidocaine has a ternary amine; however, its MBpKa was 7.7, indicating a lack of alkalinity. Clociguanil also has aromatic amines, but it is not basic. As described previously, false prediction would occur only on the basis of the calculated physicochemical values. However, these 1) "-" indicates that no atom has a pKa in the structure.
2) "T" indicates true prediction; " F " indicates false prediction. *Conflicting results exist between two or three articles, and the positive result was used in this study. structural features can be detected by visual inspection with the knowledge of organic chemistry. In likewise manner, although pentamidine has amidine groups which is a basic functional group, the MB-pKa could not be calculated. To avoid the false negative, this method requires the review of the value of calculated physicochemical properties, especially MB-pKa. The false positives were amikacin, clarithromycin, fenofibrate, flecainide, streptomycin, sumatriptan, and tetracycline. Among these compounds, tetracycline has PLD-inducing potential at high concentrations (Lowe et al., 2012) , and streptomycin was reported to have phospholipase-inhibiting activity (Brasseur et al., 1985) . Amikacin and clarithromycin are semi-synthesized from gentamicin and erythromycin which are known to be PLD inducers. Therefore, this new in silico PLD prediction method is considered able to evaluate the PLD-inducing potential of these compounds, and these false positives are acceptable. Fenofibrate is not a CAD, and thus this false positive suggests that compounds with a pKa < 7.0 or those without a basic functional group or base source (such as amide) are judged as negative before this in silico evaluation. The MB-pKa value of ketoconazole and loratadine could not be calculated because they have amide groups from which arise secondary amines by hydrolysis or metabolism (base source). Therefore, some amide compounds can be considered as a source of CADs. As described previously, there is a gap between visual inspection and in silico prediction including physicochemical property calculations for falsely predicted compounds. Therefore, the review of descriptor values or prediction results is essential to avoid missing positive compounds and to improve the concordance. In the other words, this model has a limitation which needs visual inspection of chemical structure and calculated descriptor values before final judgment, especially for non-CADs.
The prediction ability of our method was compared with Pleoman's method as a representative in silico method. Pleoman's method showed high sensitivity (93.2%) and good concordance (88.2%); however low specificity (57.1%) and low application rate (64.6%) for our data set. It is considered that MR, the third descriptor, improved specificity to 75.9%. This result supports that intermolecular force play an important role of PLD onset. On the other side, the area of score = 0 included 6 of 9 false positive compounds (Fig. 3) . This result indicates that there is the other interaction or mechanism for PLD. To investigate the evidence of the role of intermolecular interaction, other studies will be required, such as a docking study of PL and CAD.
In a previous report, we introduced a descriptor-based method for phototoxicity prediction (Haranosono et al., 2014) . In this study, we illustrated that this methodology can be adapted for PLD prediction by combining three descriptors. This methodology will be helpful and adaptable for other in silico toxicity predictions using mechanism-based descriptors.
In conclusion, we established a mechanism-based in silico PLD prediction method. We focused on molecular interactions between PL and CADs as the key events for PLD induction by PL-CADs complex formation. Chemically, these interactions can be described by physicochemical properties, and these properties depend on the chemical structure. Some toxicities are considered complicated events, and their mechanisms are unknown in most cases. Therefore, a working hypothesis-based toxicity prediction method will be effective for in silico toxicity prediction, and it will help to reveal toxicity mechanisms.
ACKNOWLEDGMENT
